{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:22:36Z","timestamp":1781122956882,"version":"3.54.1"},"reference-count":33,"publisher":"Termedia Sp. z.o.o.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Med Sci"],"published-print":{"date-parts":[[2021,5,6]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The long-term outcomes of percutaneous coronary interventions (PCIs) within coronary artery bypasses are still poor as compared to those within native coronary arteries. Thus, we aimed to assess predictors of long-term clinical outcomes after PCIs of coronary bypasses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>We enrolled 194 patients after PCIs of coronary artery bypasses at the mean age of 69.5 \u00b18.3 years (73.2% male). The primary study endpoint was a combination of target-vessel revascularization (TVR), target-lesion revascularization (TLR), myocardial infarction (MI), stroke, coronary artery bypass grafting (CABG) and death. The mean follow-up was 964 \u00b1799.1 days and was completed among 156 patients. Multivariate analysis was used to assess determinants of study endpoints during follow-up. Moreover, we compared survival curves according to the type of PCI and presence of anti-embolic protection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The primary endpoint of the study occurred in 59.7% of patients after the mean time of 669.6 \u00b1598.7 days. The TVR occurred in 37.9% of individuals, TLR in 24.2%, MI in 26.3%, stroke in 4.2%, CABG in 2.1% and death in 30.5% of patients. In Cox multivariate analysis, PCI of two or more bypasses (p &lt; 0.01), post-dilatation (p &lt; 0.05) and no-reflow (p &lt; 0.05) were the independent determinants of the primary study endpoint. No significant impact of anti-embolic protection devices on long-term outcomes was observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Percutaneous coronary interventions of two or more bypasses, post-dilatation and no-reflow are predictors of worse outcome in patients undergoing PCI within coronary artery bypass grafts.<\/jats:p><\/jats:sec>","DOI":"10.5114\/aoms.2018.75608","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T09:25:49Z","timestamp":1549358749000},"page":"628-637","source":"Crossref","is-referenced-by-count":2,"title":["Long-term outcomes of percutaneous coronary interventions within coronary artery bypass grafts"],"prefix":"10.5114","volume":"17","author":[{"given":"Rafa\u0142","family":"Januszek","sequence":"first","affiliation":[{"name":"Department of Clinical Rehabilitation, University of Physical Education, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Siudak","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Dziewierz","sequence":"additional","affiliation":[{"name":"2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland"},{"name":"2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Rakowski","sequence":"additional","affiliation":[{"name":"2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland"},{"name":"2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Dudek","sequence":"additional","affiliation":[{"name":"2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland"},{"name":"Department of Interventional Cardiology, Jagiellonian University Medical College, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw","family":"Bartu\u015b","sequence":"additional","affiliation":[{"name":"2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland"},{"name":"2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"ref-518096","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0735-1097(96)00206-9","article-title":"Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years","volume":"28","author":"Fitzgibbon GM","year":"1996","unstructured":"Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. (1996). Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years J Am Coll Cardiol. 28: 616-26.","journal-title":"J Am Coll Cardiol"},{"key":"ref-518097","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0735-1097(02)02560-3","article-title":"Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients","volume":"40","author":"Morrison DA","year":"2002","unstructured":"Morrison DA, Sethi G, Sacks J, et al, the VA Cooperative Study Group #385. (2002). Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients J Am Coll Cardiol. 40: 1951-4.","journal-title":"J Am Coll Cardiol"},{"key":"ref-518098","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0735-1097(99)00267-3","article-title":"Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994\u20131996","volume":"34","author":"O\u2019Connor GT","year":"1999","unstructured":"O\u2019Connor GT, Malenka DJ, Quinton H, et al, the Northern New England Cardiovascular Disease Study Group. (1999). Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994\u20131996 J Am Coll Cardiol. 34: 681-91.","journal-title":"J Am Coll Cardiol"},{"key":"ref-518099","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ccd.1290","article-title":"Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention","volume":"54","author":"Sdringola S","year":"2001","unstructured":"Sdringola S, Assali AR, Ghani M, et al. (2001). Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention Catheter Cardiovasc Interv. 54: 318-24.","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref-518100","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0002-9149(99)80410-X","article-title":"Features and outcomes of no-reflow after percutaneous coronary intervention","volume":"75","author":"Abbo KM","year":"1995","unstructured":"Abbo KM, Dooris M, Glazier S, et al. (1995). Features and outcomes of no-reflow after percutaneous coronary intervention Am J Cardiol. 75: 778-82.","journal-title":"Am J Cardiol"},{"key":"ref-518101","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.5114\/amsad.2016.64935","article-title":"The impact of clinical and angiographic factors on percutaneous coronary angioplasty outcomes in patients with acute ST-elevation myocardial infarction","volume":"1","author":"Barauskas M","year":"2016","unstructured":"Barauskas M, Unikas R, Tamulenaite E, Unikaite R. (2016). The impact of clinical and angiographic factors on percutaneous coronary angioplasty outcomes in patients with acute ST-elevation myocardial infarction Arch Med Sci Atheroscler Dis. 1: e150-7.","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"ref-518102","doi-asserted-by":"crossref","first-page":"795","DOI":"10.5114\/aoms.2016.59703","article-title":"The importance of two metabolic syndrome diagnostic criteria and body fat distribution in predicting clinical severity and prognosis of acute myocardial infarction","volume":"13","author":"Jelavic MM","year":"2017","unstructured":"Jelavic MM, Babic Z, Pintaric H. (2017). The importance of two metabolic syndrome diagnostic criteria and body fat distribution in predicting clinical severity and prognosis of acute myocardial infarction Arch Med Sci. 13: 795-806.","journal-title":"Arch Med Sci"},{"key":"ref-518103","doi-asserted-by":"crossref","first-page":"837","DOI":"10.5114\/aoms.2016.60374","article-title":"Clinical SYNTAX Score \u2013 a good predictor for renal artery stenosis in acute myocardial infarction patients: analysis from the REN-ACS trial","volume":"13","author":"Burlacu A","year":"2017","unstructured":"Burlacu A, Siriopol D, Nistor I, et al. (2017). Clinical SYNTAX Score \u2013 a good predictor for renal artery stenosis in acute myocardial infarction patients: analysis from the REN-ACS trial Arch Med Sci. 13: 837-44.","journal-title":"Arch Med Sci"},{"key":"ref-518104","doi-asserted-by":"crossref","first-page":"633","DOI":"10.5603\/CJ.a2018.0044","article-title":"Predictors of periprocedural complications in patients undergoing percutaneous coronary interventions within coronary bypass grafts","volume":"26","author":"Januszek RA","year":"2019","unstructured":"Januszek RA, Dziewierz A, Siudak Z, et al. (2019). Predictors of periprocedural complications in patients undergoing percutaneous coronary interventions within coronary bypass grafts Cardiol J. 26: 633-44.","journal-title":"Cardiol J"},{"key":"ref-518105","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1161\/01.CIR.100.24.2400","article-title":"Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality","volume":"100","author":"Hong MK","year":"1999","unstructured":"Hong MK, Mehran R, Dangas G, et al. (1999). Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality Circulation. 100: 2400-5.","journal-title":"Circulation"},{"key":"ref-518106","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjcard.2004.08.090","article-title":"Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device","volume":"95","author":"Giugliano GR","year":"2005","unstructured":"Giugliano GR, Kuntz RE, Popma JJ, Cutlip DE, Baim DS, Saphenous Vein Graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. (2005). Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device Am J Cardiol. 95: 173-7.","journal-title":"Am J Cardiol"},{"key":"ref-518107","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9149(00)01391-6","article-title":"Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting","volume":"87","author":"Ahmed JM","year":"2001","unstructured":"Ahmed JM, Dangas G, Lansky AJ, et al. (2001). Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting Am J Cardiol. 87: 401-5.","journal-title":"Am J Cardiol"},{"key":"ref-518108","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ccd.22479","article-title":"Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry","volume":"76","author":"Lee MS","year":"2010","unstructured":"Lee MS, Hu PP, Aragon J, et al. (2010). Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry Catheter Cardiovasc Interv. 76: 272-8.","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref-518109","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0002-9149(97)00171-9","article-title":"Late myocardial ischemic events after saphenous vein graft intervention \u2013 importance of initially \u201cnonsignificant\u201d vein graft lesions","volume":"79","author":"Ellis SG","year":"1997","unstructured":"Ellis SG, Brener SJ, DeLuca S, et al. (1997). Late myocardial ischemic events after saphenous vein graft intervention \u2013 importance of initially \u201cnonsignificant\u201d vein graft lesions Am J Cardiol. 79: 1460-4.","journal-title":"Am J Cardiol"},{"key":"ref-518110","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/CIRCULATIONAHA.109.874057","article-title":"Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the Taxus stent and intravascular ultrasound (VELETI) pilot trial","volume":"120","author":"Rod\u00e9s-Cabau J","year":"2009","unstructured":"Rod\u00e9s-Cabau J, Bertrand OF, Larose E, et al. (2009). Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the Taxus stent and intravascular ultrasound (VELETI) pilot trial Circulation. 120: 1978-86.","journal-title":"Circulation"},{"key":"ref-518111","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.amjcard.2010.08.013","article-title":"Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques","volume":"106","author":"Al-Lamee R","year":"2010","unstructured":"Al-Lamee R, Ielasi A, Latib A, et al. (2010). Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques Am J Cardiol. 106: 1721-7.","journal-title":"Am J Cardiol"},{"key":"ref-518112","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/eurheartj\/ehi736","article-title":"Platelet glycoprotein IIb\/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter based embolic protection","volume":"27","author":"Jonas M","year":"2006","unstructured":"Jonas M, Stone GW, Mehran R, et al. (2006). Platelet glycoprotein IIb\/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter based embolic protection Eur Heart J. 27: 920-8.","journal-title":"Eur Heart J"},{"key":"ref-518113","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJM199709113371103","article-title":"Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts","volume":"337","author":"Savage MP","year":"1997","unstructured":"Savage MP, Douglas JS, Fischman DL, et al, the Saphenous Vein De Novo Trial Investigators. (1997). Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts N Engl J Med. 337: 740-7.","journal-title":"N Engl J Med"},{"key":"ref-518114","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ccd.20873","article-title":"Pivotal, randomized U.S. study of the Symbiot covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial","volume":"68","author":"Turco MA","year":"2006","unstructured":"Turco MA, Buchbinder M, Popma JJ, et al. (2006). Pivotal, randomized U.S. study of the Symbiot covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial Catheter Cardiovasc Interv. 68: 379-88.","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref-518115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.0000079106.71097.1C","article-title":"Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) trial","volume":"108","author":"Stankovic G","year":"2003","unstructured":"Stankovic G, Colombo A, Presbitero P, et al, the RECOVERS Trial Investigators. (2003). Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) trial Circulation. 108: 37-42.","journal-title":"Circulation"},{"key":"ref-518116","first-page":"172","article-title":"Long term outcomes of mguard stent deployment in saphenous vein grafts and native coronary arteries: a single center experience","volume":"19","author":"Vaknin-Assa H","year":"2017","unstructured":"Vaknin-Assa H, Assali A, Lev EI, et al. (2017). Long term outcomes of mguard stent deployment in saphenous vein grafts and native coronary arteries: a single center experience Isr Med Assoc J. 19: 172-6.","journal-title":"Isr Med Assoc J"},{"key":"ref-518117","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jcin.2010.11.013","article-title":"Five-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein graft: the randomized BARRICADE (Barrier Approach to Restenosis: Restrict Intima to Curtail Adverse Events) Trial","volume":"4","author":"Stone GW","year":"2011","unstructured":"Stone GW, Goldberg S, O\u2019Shaughnessy C, et al. (2011). Five-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein graft: the randomized BARRICADE (Barrier Approach to Restenosis: Restrict Intima to Curtail Adverse Events) Trial J Am Coll Cardiol Intv. 4: 300-9.","journal-title":"J Am Coll Cardiol Intv"},{"key":"ref-518118","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcin.2010.10.003","article-title":"Continued benefit from paclitaxel-eluting compared to bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial","volume":"4","author":"Brilakis ES","year":"2011","unstructured":"Brilakis ES, Lichtenwalter C, Abdel-karim AR, et al. (2011). Continued benefit from paclitaxel-eluting compared to bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol Intv. 4: 176-82.","journal-title":"J Am Coll Cardiol Intv"},{"key":"ref-518119","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jacc.2007.05.010","article-title":"Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial","volume":"50","author":"Vermeersch P","year":"2007","unstructured":"Vermeersch P, Agostoni P, Verheye S, et al, the DELAYED RRISC Investigators. (2007). Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial J Am Coll Cardiol. 50: 261-7.","journal-title":"J Am Coll Cardiol"},{"key":"ref-518120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ccd.22720","article-title":"Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients","volume":"77","author":"Hakeem A","year":"2011","unstructured":"Hakeem A, Helmy T, Munsif S, et al. (2011). Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients Catheter Cardiovasc Interv. 77: 343-55.","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref-518121","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/joic.12324","article-title":"Drug coated balloon is less effective for treatment of DES in-stent restenosis both in native coronary arteries and saphenous vein grafts: results from a bicenter registry","volume":"29","author":"Resch M","year":"2016","unstructured":"Resch M, Ostheim P, Endemann DH, et al. (2016). Drug coated balloon is less effective for treatment of DES in-stent restenosis both in native coronary arteries and saphenous vein grafts: results from a bicenter registry J Interv Cardiol. 29: 461-8.","journal-title":"J Interv Cardiol"},{"key":"ref-518122","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jcin.2010.07.009","article-title":"Frequency and predictors of drug-eluting stent use in saphenous vein by-pass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data Cath PCI Registry","volume":"3","author":"Brilakis ES","year":"2010","unstructured":"Brilakis ES, Wang TY, Rao SV, et al. (2010). Frequency and predictors of drug-eluting stent use in saphenous vein by-pass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data Cath PCI Registry J Am Coll Cardiol Intv. 3: 1068-73.","journal-title":"J Am Coll Cardiol Intv"},{"key":"ref-518123","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jcin.2011.05.014","article-title":"Saphenous vein graft intervention","volume":"4","author":"Lee MS","year":"2011","unstructured":"Lee MS, Park SJ, Kandzari DE, et al. (2011). Saphenous vein graft intervention JACC Cardiovasc Interv. 4: 831-43.","journal-title":"JACC Cardiovasc Interv"},{"key":"ref-518124","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jacc.2005.06.073","article-title":"Randomized evaluation of the TriActiv balloon protection flush and extraction system for the treatment of saphenous vein graft disease","volume":"46","author":"Carrozza JP","year":"2005","unstructured":"Carrozza JP, Mumma M, Breall JA, et al, the PRIDE Study Investigators. (2005). Randomized evaluation of the TriActiv balloon protection flush and extraction system for the treatment of saphenous vein graft disease J Am Coll Cardiol. 46: 1677-83.","journal-title":"J Am Coll Cardiol"},{"key":"ref-518125","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jacc.2007.06.039","article-title":"The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial","volume":"50","author":"Mauri L","year":"2007","unstructured":"Mauri L, Cox D, Hermiller J, et al. (2007). The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial J Am Coll Cardiol. 50: 1442-9.","journal-title":"J Am Coll Cardiol"},{"key":"ref-518126","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ccd.10474","article-title":"Is adjunctive balloon postdilatation necessary after coronary stent deployment? Final results from the POSTIT trial","volume":"59","author":"Brodie BR","year":"2003","unstructured":"Brodie BR, Cooper C, Jones M, et al. (2003). Is adjunctive balloon postdilatation necessary after coronary stent deployment? Final results from the POSTIT trial Catheter Cardiovasc Interv. 59: 184-92.","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref-518127","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-8703(03)00309-0","article-title":"Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft","volume":"146","author":"Leborgne L","year":"2003","unstructured":"Leborgne L, Cheneau E, Pichard A, et al. (2003). Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft Am Heart J. 146: 501-6.","journal-title":"Am Heart J"},{"key":"ref-518128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.amjcard.2009.09.006","article-title":"Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions","volume":"105","author":"Hong YJ","year":"2010","unstructured":"Hong YJ, Pichard AD, Mintz GS, et al. (2010). Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions Am J Cardiol. 105: 179-85.","journal-title":"Am J Cardiol"}],"container-title":["Archives of Medical Science"],"original-title":[],"link":[{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-87146-64229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-87146-64229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T11:43:19Z","timestamp":1662896599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.archivesofmedicalscience.com\/Long-term-outcomes-of-percutaneous-coronary-interventions-within-coronary-artery,87146,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["87146"],"URL":"https:\/\/doi.org\/10.5114\/aoms.2018.75608","relation":{},"ISSN":["1734-1922","1896-9151"],"issn-type":[{"value":"1734-1922","type":"print"},{"value":"1896-9151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]}}}